• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定由U79260(FTO)的(-1)读码框产生的微卫星高度不稳定(MSI-H)肿瘤特异性细胞毒性T细胞表位。

Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).

作者信息

Linnebacher Michael, Wienck Anne, Boeck Inga, Klar Ernst

机构信息

Department of General, Thoracic, Vascular and Transplant Surgery, University of Rostock, Rostock, Germany.

出版信息

J Biomed Biotechnol. 2010;2010:841451. doi: 10.1155/2010/841451. Epub 2010 Mar 18.

DOI:10.1155/2010/841451
PMID:20339516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2842904/
Abstract

Microsatellite instability (MSI-H) induced by defects of the DNA mismatch repair system results in insertion or deletion of single nucleotides at short repetitive DNA sequences. About 15% of sporadic and approximately 90% of hereditary nonpolyposis colorectal cancers display MSI-H. When affecting coding regions, MSI-H results in frameshift mutations and expression of corresponding frameshift peptides (FSPs). Functional tumor promoting relevance has been demonstrated for a growing number of genes frequently hit by MSI-H. Contrary, immune reactions against FSPs are involved in the immune surveillance of MSI-H cancers. Here, we provide conclusive data that the (-1) frame of U79260(FTO) encodes an HLA-A0201-restricted cytotoxic T cell epitope (FSP11; TLSPGWSAV). T cells specific for FSP11 efficiently recognized HLA-A0201((pos)) tumor cells harboring the mutated reading frame. Considering the exceptionally high mutation rate of U79260(FTO) in MSI-H colorectal carcinoma (81.8%), this recommends that FSP11 be a component of future vaccines.

摘要

DNA错配修复系统缺陷引起的微卫星不稳定性(MSI-H)导致短重复DNA序列处单核苷酸的插入或缺失。约15%的散发性结直肠癌和大约90%的遗传性非息肉病性结直肠癌表现为MSI-H。当影响编码区域时,MSI-H会导致移码突变和相应移码肽(FSPs)的表达。越来越多经常受MSI-H影响的基因已被证明具有促进肿瘤功能的相关性。相反,针对FSPs的免疫反应参与了MSI-H癌症的免疫监视。在此,我们提供确凿数据表明,U79260(FTO)的(-1)读框编码一种HLA-A0201限制性细胞毒性T细胞表位(FSP11;TLSPGWSAV)。对FSP11特异的T细胞能有效识别携带突变读框的HLA-A0201(阳性)肿瘤细胞。鉴于MSI-H结直肠癌中U79260(FTO)的突变率异常高(81.8%),这表明FSP11应成为未来疫苗的一个组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/2b856f97a650/JBB2010-841451.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/ae496b4e3402/JBB2010-841451.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/1e1f409e92c4/JBB2010-841451.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/51dd24383006/JBB2010-841451.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/8edfc0f2b2a6/JBB2010-841451.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/2b856f97a650/JBB2010-841451.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/ae496b4e3402/JBB2010-841451.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/1e1f409e92c4/JBB2010-841451.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/51dd24383006/JBB2010-841451.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/8edfc0f2b2a6/JBB2010-841451.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f710/2842904/2b856f97a650/JBB2010-841451.005.jpg

相似文献

1
Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).鉴定由U79260(FTO)的(-1)读码框产生的微卫星高度不稳定(MSI-H)肿瘤特异性细胞毒性T细胞表位。
J Biomed Biotechnol. 2010;2010:841451. doi: 10.1155/2010/841451. Epub 2010 Mar 18.
2
Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells.DNA错配修复缺陷癌细胞中移码突变产生的免疫原性肽。
Cancer Immun. 2004 Nov 25;4:14.
3
An MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopes.MSI 肿瘤中 MSH3 编码区微卫星的移码突变可编码 HLA-A0201 限制性 CD8+细胞毒性 T 细胞表位。
PLoS One. 2011;6(11):e26517. doi: 10.1371/journal.pone.0026517. Epub 2011 Nov 14.
4
Identification of an HLA-A0201-restricted CTL epitope generated by a tumor-specific frameshift mutation in a coding microsatellite of the OGT gene.在OGT基因编码微卫星中由肿瘤特异性移码突变产生的HLA - A0201限制性CTL表位的鉴定。
J Clin Immunol. 2003 Sep;23(5):415-23. doi: 10.1023/a:1025329819121.
5
A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells.一种由转化生长因子β受体II(TGF betaRII)移码突变产生的细胞毒性T淋巴细胞(CTL)表位,可被HLA - A2限制性CD8 + T细胞识别。
Cancer Immunol Immunother. 2001 Nov;50(9):469-76. doi: 10.1007/s002620100222.
6
Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.林奇综合征合并微卫星不稳定结直肠癌患者血清中针对移码肽的抗体。
Fam Cancer. 2010 Jun;9(2):173-9. doi: 10.1007/s10689-009-9307-z.
7
Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens.移码肽衍生的T细胞表位:新型肿瘤特异性抗原的来源
Int J Cancer. 2001 Jul 1;93(1):6-11. doi: 10.1002/ijc.1298.
8
Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.移码突变衍生的新抗原构成了具有不稳定微卫星血液恶性肿瘤的患者的免疫治疗靶标:移码肽治疗 MSI+血液癌症。
Eur J Cancer. 2013 Jul;49(11):2587-95. doi: 10.1016/j.ejca.2013.02.035. Epub 2013 Apr 2.
9
[Pathogenesis of microsatellite-unstable colorectal cancer. Evaluation of new diagnostic and therapeutic options].[微卫星不稳定型结直肠癌的发病机制。新诊断与治疗选择的评估]
Pathologe. 2013 Nov;34 Suppl 2:277-81. doi: 10.1007/s00292-013-1826-6.
10
Screening and identification of HLA-A2-restricted neoepitopes for immunotherapy of non-microsatellite instability-high colorectal cancer.筛选和鉴定 HLA-A2 限制性新表位用于非微卫星不稳定高结直肠癌的免疫治疗。
Sci China Life Sci. 2022 Mar;65(3):572-587. doi: 10.1007/s11427-021-1944-5. Epub 2021 Jul 2.

引用本文的文献

1
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.生物标志物导向的靶向治疗联合度伐利尤单抗治疗晚期非小细胞肺癌:一项 2 期伞式试验。
Nat Med. 2024 Mar;30(3):716-729. doi: 10.1038/s41591-024-02808-y. Epub 2024 Feb 13.
2
FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review.FTO在胃肠道癌中起关键作用,可能成为免疫治疗的靶点:最新综述
Front Oncol. 2023 Oct 12;13:1241357. doi: 10.3389/fonc.2023.1241357. eCollection 2023.
3
Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer.

本文引用的文献

1
Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations.微卫星不稳定的结直肠癌中的肿瘤浸润淋巴细胞与移码突变的数量和谱相关。
Mod Pathol. 2009 Sep;22(9):1186-95. doi: 10.1038/modpathol.2009.80. Epub 2009 Jun 5.
2
Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.对HNPCC患者和健康的HNPCC突变携带者中移码诱导新肽的免疫反应。
Gastroenterology. 2008 Apr;134(4):988-97. doi: 10.1053/j.gastro.2008.01.015. Epub 2008 Jan 11.
3
FTO: the first gene contributing to common forms of human obesity.
肿瘤新生抗原:结直肠癌免疫治疗的一个有前景的靶点。
Dis Markers. 2022 Feb 15;2022:8270305. doi: 10.1155/2022/8270305. eCollection 2022.
4
RNA m6A methylation regulators in ovarian cancer.卵巢癌中的RNA m6A甲基化调节因子
Cancer Cell Int. 2021 Nov 18;21(1):609. doi: 10.1186/s12935-021-02318-8.
5
N6-Methyladenosine Modification of PTTG3P Contributes to Colorectal Cancer Proliferation YAP1.PTTG3P的N6-甲基腺苷修饰促进结直肠癌增殖 Yes相关蛋白1(YAP1)
Front Oncol. 2021 Sep 30;11:669731. doi: 10.3389/fonc.2021.669731. eCollection 2021.
6
N-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction.N6-甲基腺苷作为结直肠癌的生物学和临床决定因素:进展和未来方向。
Theranostics. 2021 Jan 1;11(6):2581-2593. doi: 10.7150/thno.52366. eCollection 2021.
7
The Identification of Critical mA RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma.关键的mA RNA甲基化调节因子作为前列腺腺癌恶性预后因素的鉴定
Front Genet. 2020 Dec 4;11:602485. doi: 10.3389/fgene.2020.602485. eCollection 2020.
8
The Landscape of Tumor-Specific Antigens in Colorectal Cancer.结直肠癌中肿瘤特异性抗原的概况
Vaccines (Basel). 2020 Jul 10;8(3):371. doi: 10.3390/vaccines8030371.
9
Microsatellite instability: a review of what the oncologist should know.微卫星不稳定性:肿瘤学家应了解的内容综述
Cancer Cell Int. 2020 Jan 13;20:16. doi: 10.1186/s12935-019-1091-8. eCollection 2020.
10
Genomic correlates of response to immune checkpoint blockade.免疫检查点阻断治疗反应的基因组相关性。
Nat Med. 2019 Mar;25(3):389-402. doi: 10.1038/s41591-019-0382-x. Epub 2019 Mar 6.
FTO:首个导致人类常见肥胖类型的基因。
Obes Rev. 2008 May;9(3):246-50. doi: 10.1111/j.1467-789X.2008.00481.x. Epub 2008 Mar 26.
4
Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.β-连环蛋白/Tcf/Lef信号通路对结肠癌细胞中AKT1表达的调控
Carcinogenesis. 2005 Sep;26(9):1503-12. doi: 10.1093/carcin/bgi120. Epub 2005 May 11.
5
Microsatellite instability of selective target genes in HNPCC-associated colon adenomas.HNPCC相关结肠腺瘤中选择性靶基因的微卫星不稳定性
Oncogene. 2005 Apr 7;24(15):2525-35. doi: 10.1038/sj.onc.1208456.
6
Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells.DNA错配修复缺陷癌细胞中移码突变产生的免疫原性肽。
Cancer Immun. 2004 Nov 25;4:14.
7
Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.具有微卫星不稳定性的结直肠癌中的肿瘤浸润淋巴细胞被激活且具有细胞毒性。
Br J Surg. 2004 Apr;91(4):469-75. doi: 10.1002/bjs.4472.
8
Identification of an HLA-A0201-restricted CTL epitope generated by a tumor-specific frameshift mutation in a coding microsatellite of the OGT gene.在OGT基因编码微卫星中由肿瘤特异性移码突变产生的HLA - A0201限制性CTL表位的鉴定。
J Clin Immunol. 2003 Sep;23(5):415-23. doi: 10.1023/a:1025329819121.
9
Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.微卫星不稳定的结肠癌中移码突变肽的肿瘤特异性免疫识别
Cancer Res. 2003 Sep 1;63(17):5564-72.
10
Comparative analysis of mutation frequency of coding and non coding short mononucleotide repeats in mismatch repair deficient colorectal cancers.错配修复缺陷型结直肠癌中编码和非编码短单核苷酸重复序列突变频率的比较分析
Oncogene. 2002 Nov 14;21(52):8062-6. doi: 10.1038/sj.onc.1206013.